|
Intensive_Care_Unit
|
Intensive_Care_Unit |
|
|
pancreatic_cancer
|
pancreatic_cancer |
|
|
antipsychotic_drug
|
antipsychotic_drug |
|
|
Neurological_medication_prior_to_current_disease
|
Neurological_medication_prior_to_current_disease |
|
|
bacteremia
|
bacteremia |
|
|
Bacterial_infections_within_the_last_30_days
|
Bacterial_infections_within_the_last_30_days |
|
|
Creatinine:MCnc:Pt:Synv_fld:Qn
|
Creatinine:MCnc:Pt:Synv_fld:Qn |
|
|
CSF_RBC_Count
|
CSF_RBC_Count |
|
|
Care_coordinator_visit
|
Care_coordinator_visit |
|
|
Severe_Cognitive_Impairments
|
Severe_Cognitive_Impairments |
|
|
alveolar_macrophage
|
alveolar_macrophage |
|
|
driving_pressure
|
driving_pressure |
|
|
Did_any_opportunistic_infections,_AIDS-defining_illnesses_or_STI_(sexually_transmitted_infection)_occur_during_SARS-CoV-2_infection?
|
Did_any_opportunistic_infections,_AIDS-defining_illnesses_or_STI_(sexually_transmitted_infection)_occur_during_SARS-CoV-2_infection? |
|
|
Human immunodeficiency virus infection
|
GECCO_2.16.840.1.113883.3.1937.777.53.2.2.1200 |
[Is the patient infected with HIV?, Ist der/die Patient*in HIV-infiziert? ] |
|
Forced_Expiratory_Volume_in_1_Second_to_Forced_Vital_Capacity_Ratio_Measurement
|
Forced_Expiratory_Volume_in_1_Second_to_Forced_Vital_Capacity_Ratio_Measurement |
|
|
HLA-B57*01
|
HLA-B57*01 |
|
|
long_acting_beta_agonist
|
long_acting_beta_agonist |
|
|
Regular_use_of_inhaler
|
Regular_use_of_inhaler |
|
|
sufentanil
|
sufentanil |
|
|
What_type_of_diabetes
|
What_type_of_diabetes |
|
